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1. INTRODUCTION {#jcla23191-sec-0005}
===============

Annual seasonal influenza epidemics of variable severity result in significant morbidity and mortality worldwide.[1](#jcla23191-bib-0001){ref-type="ref"} Since avian influenza was first identified in Shanghai, China, in March 2013, there have been a total of five epidemics.[2](#jcla23191-bib-0002){ref-type="ref"} Patients with influenza virus mostly present with fever and cough are prone to progression to viral pneumonia. Moreover, in the event of acute respiratory distress and important organ dysfunction, the fatality rate is even higher. In addition, late diagnosis of community‐acquired influenza A virus infection is associated with a delay in ICU admission, greater possibilities of respiratory and renal failure, and higher mortality rate. Delay in diagnosis of flu is an independent variable related to death. Therefore, early diagnosis and treatment with antivirals are critical for achieving effective therapeutic outcomes.[3](#jcla23191-bib-0003){ref-type="ref"}

At present, molecular assays (eg, nucleic acid amplification tests and antigen tests) targeting respiratory tract specimens are recommended as critical diagnostic tests for clinical decision‐making according to influenza clinical practice guidelines in different countries.[4](#jcla23191-bib-0004){ref-type="ref"}, [5](#jcla23191-bib-0005){ref-type="ref"} However, these tests are limited by some technical provisions and specifications for molecular assay utilization, especially in underdeveloped areas and community hospitals. Furthermore, antigen tests have poor sensitivity to some influenza viruses.[6](#jcla23191-bib-0006){ref-type="ref"}, [7](#jcla23191-bib-0007){ref-type="ref"} Recently, it was reported that hematological inflammatory indexes based on blood cell analysis had an important predictive value for the prognosis of infections, cancers, and many other diseases.[8](#jcla23191-bib-0008){ref-type="ref"}, [9](#jcla23191-bib-0009){ref-type="ref"}, [10](#jcla23191-bib-0010){ref-type="ref"} This study aimed to conduct a retrospective analysis of hematological inflammatory parameters (eg, neutrophils, lymphocytes, platelets) and blood cell count indexes, particularly the NLR, in hospitalized patients with suspected influenza. Moreover, this study aimed to validate hematological indexes as potential indicators to discriminate influenza virus infection from non‐influenza infection, which would facilitate a clear diagnosis and enable the initiation of antiviral treatment as early as possible when molecular assays for respiratory specimen tests are not performed.

2. MATERIALS AND METHODS {#jcla23191-sec-0006}
========================

2.1. Study population {#jcla23191-sec-0007}
---------------------

The present study retrospectively enrolled 307 suspected influenza virus‐infected patients with typical acute onset of respiratory symptoms (cough, rhinorrhea, and congestion), myalgia and headache with or without fever at the First Affiliated Hospital of Soochow University from January 2017 to June 2019. The diagnostic criteria for influenza virus infection included the guidelines for the diagnosis and treatment of influenza combined with positive influenza virus nucleic acid detection. Bacterial infection was confirmed by bacterial cultures. Finally, 107 patients were diagnosed with definite influenza virus infection (influenza virus positive), of which 88 had influenza A, 16 had influenza B, and 3 had combined influenza A and B (53 male and 54 female; age range: 9‐91 years; mean age: 56.54 ± 18.84 years). A total of 109 patients with respiratory symptoms were diagnosed with bacterial infection by bacterial cultures, including 33 cases of *Klebsiella pneumoniae*, 9 cases of *Pseudomonas aeruginosa*, 28 cases of *Acinetobacter baumannii,* and 39 cases of other bacterial species (79 male and 30 female; age range: 13‐92 years; mean age: 63.46 ± 18.53 years). A total of 91 patients were identified as negative controls with typical respiratory symptoms; these patients were negative for both the nucleic acid and bacterial culture results (58 male and 33 female; age range: 23‐95 years; mean age: 56.04 ± 18.53 years). In addition, 100 individuals were recruited for the control group (healthy controls) (60 male and 40 female; age range: 26‐64 years; mean age: 41.53 ± 9.88 years) (Figure [1](#jcla23191-fig-0001){ref-type="fig"}).

![Flowchart of the included patients. All patients with respiratory symptoms and without other diseases. There was no significant difference in age and sex among all enrolled people](JCLA-34-e23191-g001){#jcla23191-fig-0001}

2.2. Blood analysis for the determination of infection {#jcla23191-sec-0008}
------------------------------------------------------

The complete blood count was routinely examined in hospitalized patients with suspected influenza virus infection in the study. Two milliliters of peripheral blood was placed in hemogram tubes with ethylenediaminetetraacetic acid (EDTA). The blood count was determined using an automated hematology analyzer (Sysmex‐20 instrument, Sysmex). The NLR was calculated as neutrophils/lymphocytes, the PLR as platelets/lymphocytes, and the PNR as platelets/neutrophils. The viral nucleic acid of respiratory tract specimens was detected using a Viral Nucleic Acid Isolation Kit (silica‐based spin column) (BioPerfectus Technologies) and an Influenza A and B Polymerase Chain Reaction (PCR) Fluorescence Diagnostic Kit (BioPerfectus Technologies) with a Roche LightCycler 480 sequence detection system (Roche) according to the manufacturer\'s instructions.

2.3. Statistical analysis {#jcla23191-sec-0009}
-------------------------

Continuous variables are summarized as the mean ± SD (standard deviation). Student\'s *t* test for independent samples was used to compare continuous variables. A significance level of 0.05 was used for all statistical tests. SPSS software version 22.0 (SPSS) was used for all statistical analyses.

3. RESULTS {#jcla23191-sec-0010}
==========

3.1. Comparison of diagnostic sensitivity of N, L, and NLR {#jcla23191-sec-0011}
----------------------------------------------------------

The results showed that WBC, N, RDW, NLR, and PLR increased significantly in the influenza virus infection group compared with the healthy control (*P* \< .01 for all), while L, RBC, Hb, PLT, and PNR decreased (*P* \< .01 for all) (Table [1](#jcla23191-tbl-0001){ref-type="table"}). Specifically, the sensitivity of NLR detection was higher than the common systemic inflammatory markers, including neutrophils and lymphocytes (Table [2](#jcla23191-tbl-0002){ref-type="table"}). No significant differences were found between influenza virus A and B.

###### 

Comparison of hematological parameters between the influenza virus infection group and the healthy control group

                   Influenza virus infection (N = 107)   Healthy control (N = 100)   *P* value
  ---------------- ------------------------------------- --------------------------- -----------------------------------------------------
  WBC (10^9^/L)    8.005 ± 6.287                         5.981 ± 1.175               .002[\*\*](#jcla23191-note-0005){ref-type="fn"}
  N (10^9^/L)      6.247 ± 5.700                         3.226 ± 0.913               \<.001[\*\*\*](#jcla23191-note-0006){ref-type="fn"}
  L (10^9^/L)      1.167 ± 1.341                         2.111 ± 0.429               \<.001[\*\*\*](#jcla23191-note-0006){ref-type="fn"}
  RBC (10^12^/L)   3.877 ± 0.921                         4.835 ± 0.445               \<.001[\*\*\*](#jcla23191-note-0006){ref-type="fn"}
  Hb (g/L)         116.720 ± 28.428                      146.18 ± 12.977             \<.001[\*\*\*](#jcla23191-note-0006){ref-type="fn"}
  RDW (%)          13.628 ± 2.820                        12.213 ± 0.546              \<.001[\*\*\*](#jcla23191-note-0006){ref-type="fn"}
  PLT (10^9^/L)    169.869 ± 93.379                      229.38 ± 47.260             \<.001[\*\*\*](#jcla23191-note-0006){ref-type="fn"}
  NLR              8.877 ± 9.855                         1.595 ± 0.507               \<.001[\*\*\*](#jcla23191-note-0006){ref-type="fn"}
  PNR              53.338 ± 58.693                       75.406 ± 25.935             \<.001[\*\*\*](#jcla23191-note-0006){ref-type="fn"}
  PLR              241.042 ± 212.375                     112.632 ± 30.255            \<.001[\*\*\*](#jcla23191-note-0006){ref-type="fn"}

Student\'s *t* test for independent samples was used to compare continuous variables.

Abbreviations: Hb, hemoglobin; L, lymphocyte; N, neutrophil; NLR, neutrophil‐to‐lymphocyte ratio; PLR, platelet‐to‐lymphocyte ratio; PLT, platelet; PNR, platelet‐to‐neutrophil ratio; RBC, red blood cell; RDW, red blood cell distribution width; WBC, white blood cell.
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###### 

Comparison of the diagnostic sensitivity for N, L, and NLR

                Influenza virus infection (N = 107)   Healthy control (N = 100)   Reference range   Sensitivity   *P* value
  ------------- ------------------------------------- --------------------------- ----------------- ------------- -----------------------------------------------------
  N (10^9^/L)   6.247 ± 5.700                         3.226 ± 0.913               1.8‐6.3           37.40%        \<.001[\*\*\*](#jcla23191-note-0010){ref-type="fn"}
  L (10^9^/L)   1.167 ± 1.341                         2.111 ± 0.429               1.1‐3.2           60.75%        \<.001[\*\*\*](#jcla23191-note-0010){ref-type="fn"}
  NLR           8.877 ± 9.855                         1.595 ± 0.507               0.581‐2.61        70.09%        \<.001[\*\*\*](#jcla23191-note-0010){ref-type="fn"}

The reference range of NLR was the 95% confidence interval of NLR in the control group, *P* \< .01. Student\'s *t* test for independent samples was used to compare continuous variables.

*P* \< .05.

*P* \< .01.

*P* \< .001.
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3.2. Comparison of hematological parameters between influenza virus‐positive infection and influenza virus‐negative infection {#jcla23191-sec-0012}
-----------------------------------------------------------------------------------------------------------------------------

In the present paper, we found that PLT was lower in the influenza virus infection group (169.869 ± 93.379) than in the negative control group (226.209 ± 119.245) (*P* \< .001), while Hb was higher (*P* \< .05). Moreover, the other routine blood parameters did not differ significantly between the two groups (*P* \> .05) (Table [3](#jcla23191-tbl-0003){ref-type="table"}). In addition, L and PLT increased to normal levels concomitantly when influenza patients were completely cured (*P* \< .05). Furthermore, no other hematological parameters were found to have significance with a complete cure of influenza (*P* \> .05) (Table [4](#jcla23191-tbl-0004){ref-type="table"}).

###### 

Comparison of hematological parameters between influenza virus infection and negative control

                   Influenza virus infection (N = 107)   Negative control (N = 91)   *P* value
  ---------------- ------------------------------------- --------------------------- -----------------------------------------------------
  WBC (10^9^/L)    8.005 ± 6.287                         8.491 ± 4.725               .545
  N (10^9^/L)      6.247 ± 5.700                         6.538 ± 4.613               .697
  L (10^9^/L)      1.167 ± 1.341                         1.111 ± 0.656               .716
  RBC (10^12^/L)   3.877 ± 0.921                         3.671 ± 0.33                .103
  Hb (g/L)         116.720 ± 28.428                      109.143 ± 24.265            .047[\*](#jcla23191-note-0012){ref-type="fn"}
  RDW (%)          13.628 ± 2.820                        14.136 ± 3.027              .223
  PLT (10^9^/L)    169.869 ± 93.379                      226.209 ± 119.245           \<.001[\*\*\*](#jcla23191-note-0014){ref-type="fn"}
  NLR              8.877 ± 9.855                         8.905 ± 9.617               .984
  PNR              53.338 ± 58.693                       52.994 ± 7.923              .967
  PLR              241.042 ± 212.375                     286.538 ± 332.511           .967

Student\'s *t* test for independent samples was used to compare continuous variables.

*P* \< .05.

*P* \< .01.

*P* \< .001.
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###### 

Comparison of hematological parameters before and after treatments

                   Pretreatment (N = 64)   Posttreatment (N = 64)   *P* value
  ---------------- ----------------------- ------------------------ -------------------------------------------------
  WBC (10^9^/L)    8.490 ± 5.567           8.519 ± 4.744            .975
  N (10^9^/L)      6.858 ± 5.392           6.444 ± 4.561            .640
  L (10^9^/L)      0.996 ± 0.606           1.365 ± 0.765            .003[\*\*](#jcla23191-note-0017){ref-type="fn"}
  RBC (10^12^/L)   4.054 ± 0.794           3.896 ± 0.738            .245
  Hb (g/L)         122.594 ± 23.525        117.016 ± 22.424         .172
  RDW (%)          13.775 ± 3.137          15.221 ± 12.490          .370
  PLT (10^9^/L)    188.5 ± 89.146          232 ± 103.899            .012[\*](#jcla23191-note-0016){ref-type="fn"}
  NLR              10.179 ± 11.003         7.228 ± 11.290           .137
  PNR              48.437 ± 44.892         51.849 ± 36.353          .637
  PLR              255.983 ± 180.771       212.560 ± 126.046        .117
  WBC              8.490 ± 5.567           8.519 ± 4.744            .975

Student\'s *t* test for independent samples was used to compare continuous variables.

*P* \< .05.

*P* \< .01.

*P* \< .001.
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3.3. The differential sensitivity of hematological parameters between influenza virus infection and bacterial infection {#jcla23191-sec-0013}
-----------------------------------------------------------------------------------------------------------------------

Compared with bacterial infection, RBC, Hb, and PNR markedly increased in influenza virus infection, while WBC, RDW, neutrophils, and NLR decreased (Table [5](#jcla23191-tbl-0005){ref-type="table"}).

###### 

Comparison of hematological parameters between influenza virus infection and bacterial infection

                   Influenza virus infection (N = 107)   Bacterial infection (N = 109)   *P* value
  ---------------- ------------------------------------- ------------------------------- -----------------------------------------------------
  WBC (10^9^/L)    8.005 ± 6.287                         9.792 ± 4.525                   .039[\*](#jcla23191-note-0020){ref-type="fn"}
  N (10^9^/L)      6.247 ± 5.700                         8.058 ± 4.679                   .027[\*](#jcla23191-note-0020){ref-type="fn"}
  L (10^9^/L)      1.167 ± 1.341                         0.998 ± 1.076                   .373
  RBC (10^12^/L)   3.877 ± 0.921                         3.453 ± 0.837                   .002[\*\*](#jcla23191-note-0021){ref-type="fn"}
  Hb (g/L)         116.720 ± 28.428                      105.625 ± 24.964                .008[\*\*](#jcla23191-note-0021){ref-type="fn"}
  RDW (%)          13.628 ± 2.820                        14.764 ± 2.442                  .006[\*\*](#jcla23191-note-0021){ref-type="fn"}
  PLT (10^9^/L)    169.869 ± 93.379                      146.653 ± 79.849                .086
  NLR              8.877 ± 9.855                         18.933 ± 38.447                 .009[\*\*](#jcla23191-note-0021){ref-type="fn"}
  PNR              53.338 ± 58.693                       26.344 ± 22.243                 \<.001[\*\*\*](#jcla23191-note-0022){ref-type="fn"}
  PLR              241.042 ± 212.375                     282.231 ± 335.472               .283

Student\'s *t* test for independent samples was used to compare continuous variables.

*P* \< .05.

*P* \< .01.

*P* \< .001.

John Wiley & Sons, Ltd

4. DISCUSSION {#jcla23191-sec-0014}
=============

A late diagnosis of influenza virus infection is associated with greater possibilities of respiratory and renal failure and a higher mortality rate.[3](#jcla23191-bib-0003){ref-type="ref"} Due to shared routes of transmission, coinfection with influenza virus and bacteria has become common among individuals, making it even more complicated to confirm influenza virus infection and choose accurate treatments. As such, we demonstrated the relationships between laboratory parameters and influenza virus infections, bacterial infections and non‐influenza virus infections.

Blood cell count analysis is a simple, effective, and rapid laboratory diagnostic basis for evaluating infectious inflammatory responses.[11](#jcla23191-bib-0011){ref-type="ref"} The influenza virus‐infected patients analyzed in this paper were mainly elderly people. Additionally, elderly people were mainly involved as the controls in this study. Therefore, the age and sex distribution of the selected controls were as close as possible to those of the influenza virus‐infected group. The results showed that routine blood indicators were independent of age and sex, consistent with the findings of previous literature reports.[12](#jcla23191-bib-0012){ref-type="ref"} This study found that many hematological parameters changed significantly due to influenza virus infection, such as PLT, WBC, RBC, Hb, and RDW. Influenza virus infection induced a relatively increased N count and a relatively decreased L count, which was different from the changes caused by other common viruses such as adenovirus, respiratory syncytial virus, EB virus, human herpes virus type 6, and enterovirus.[13](#jcla23191-bib-0013){ref-type="ref"}, [14](#jcla23191-bib-0014){ref-type="ref"} In addition, NLR was as a more sensitive parameter for influenza virus infection than the other cell count parameters in our study, which was consistent with reports on many other diseases, such as lung cancer and swine flu.[8](#jcla23191-bib-0008){ref-type="ref"}, [15](#jcla23191-bib-0015){ref-type="ref"}, [16](#jcla23191-bib-0016){ref-type="ref"}, [17](#jcla23191-bib-0017){ref-type="ref"}, [18](#jcla23191-bib-0018){ref-type="ref"} A hemogram is a basic investigation performed in all admitted patients (including patients with respiratory tract infection), and NLR can be easily calculated from the results. Previous studies have independently assessed the clinical significance of these blood markers in various patients, specifically in those with malignancies. Here, we evaluated the early predictive value of NLR in influenza virus infection. Additionally, no significant difference in hematological parameters was found between different subtypes of influenza virus A (20 H1N1, 9H7N9, and 10 H3), but further elaboration is needed in more cases.

Among patients with typical symptoms of respiratory influenza infection, only approximately 40% were truly infected by influenza virus during its seasonal peak based on the results of nucleic acid detection, and this percentage was much lower during the non‐epidemic season of influenza.[19](#jcla23191-bib-0019){ref-type="ref"} The differential diagnosis of influenza virus from other microbial infections based only on clinical symptoms before performing the nucleic acid test is very challenging. In our retrospective analysis of the hematological parameters of suspected influenza patients, PLT count was significantly lower (169.869 ± 93.379) in influenza virus‐positive patients than in negative controls (226.209 ± 119.245) (*P* \< .001), suggesting that decreased PLT counts could differentiate influenza virus infections from others. Furthermore, PLT count returned to a normal level concomitantly while influenza patients were completely cured, indicating that PLT count had a high correlation and specificity in influenza laboratory diagnosis. This was the first study to present real laboratory data to confirm other reports on the mechanism of platelet inhibition induced by influenza virus. It has been reported that influenza virus could induce uncontrolled platelet activation to fuel a harmful inflammatory response in the respiratory tract.[20](#jcla23191-bib-0020){ref-type="ref"}, [21](#jcla23191-bib-0021){ref-type="ref"}, [22](#jcla23191-bib-0022){ref-type="ref"}, [23](#jcla23191-bib-0023){ref-type="ref"} We hypothesized that such excessive activation of platelets by influenza virus may lead to a markedly decreased platelet count compared with other respiratory tract infections. Nevertheless, the detailed mechanism can be complex and further studies are warranted to confirm these associations.

In addition, our data demonstrated that RBC, Hb, and PNR were higher in influenza virus infection than in bacterial infection. They were differential diagnostic indicators for infection caused by influenza virus vs bacteria. At present, it is well known that influenza hemagglutinin readily binds to sialic acid receptors on the membranes of red blood cells, causing red blood cells to clump together or agglutinate.[24](#jcla23191-bib-0024){ref-type="ref"} Some bacterial infections cause intravascular hemolysis leading to sepsis, which reduces the red blood cell count[25](#jcla23191-bib-0025){ref-type="ref"} and may be why bacterial infections cause more significant reduction in red blood cells.

In conclusion, NLR was found to have a high sensitivity in detecting influenza virus infection. PLT count had a high correlation and specificity to preliminarily discriminate influenza virus infection from suspected influenza virus infection. In addition, RBC, Hb, NLR, and PNR showed some diagnostic value for differentiating between influenza virus infection and bacterial infection. In summary, some hematological indexes (eg, PLT, NLR, RBC, and Hb) as simple early laboratory indicators have promising value in the diagnosis of influenza virus infection. Further investigation of the reference ranges of hematological parameters based on influenza virus infection and individual physiological levels is warranted.
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